Boston Scientific CorporationBSXNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank57
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P57
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 31.99% |
| 2024 | 37.24% |
| 2023 | 64.02% |
| 2022 | -18.40% |
| 2021 | 24.01% |
| 2020 | -17.86% |
| 2019 | 492.26% |
| 2018 | -78.26% |
| 2017 | 46.71% |
| 2016 | 62.00% |